| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +1.83% | -1.63% | +3.46% | +3.46% | — |
| 14d | 2 | +50.00% | -8.89% | -5.12% | -3.77% | -3.77% | — |
| 30d | 2 | +50.00% | -16.11% | -3.72% | -12.39% | -12.39% | — |
| 60d | 2 | +100.00% | +0.13% | +1.90% | -1.77% | -1.77% | — |
| 90d | 2 | +100.00% | -5.53% | +3.01% | -8.54% | -8.54% | — |
| 180d | 2 | +50.00% | -11.74% | +4.82% | -16.56% | -16.56% | — |
| 1y | 2 | +50.00% | +81.97% | +18.98% | +62.98% | +62.98% | — |
| 2y | 2(1 pending) | +100.00% | -48.39% | +39.03% | -87.41% | -87.41% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 253,000 | — | — | 253,000 | Jun 29, 2026 | Jun 29, 2026 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 660,000 | — | — | 660,000 | Jul 16, 2025 | Jul 18, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 330,000 | — | — | 330,000 | Jul 16, 2025 | Jul 18, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASE President and COO | 12,512 | $0.79 | $9.9K | 12,512 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASE President and COO | 12,512 | $0.79 | $9.9K | 12,512 | Jun 5, 2025 | Jun 20, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 595,000 | — | — | 595,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 598,500 | — | — | 598,500 | Jun 5, 2025 | Jun 20, 2025 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 157,500 | — | — | 157,500 | Dec 4, 2024 | Dec 6, 2024 ↗ | View → |
| IMUX IMMUNIC, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | Jul 12, 2024 | Jul 12, 2024 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 28,125 | — | — | 28,125 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 168,750 | — | — | 168,750 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Feb 23, 2023 | Feb 27, 2023 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALE Chief Operating Officer | 17,344 | $2.15 | $37.3K | 0 | Sep 12, 2022 | Sep 14, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Apr 8, 2022 | Apr 12, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 87,498 | — | — | 87,498 | Apr 8, 2022 | Apr 12, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Feb 3, 2022 | Feb 4, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jul 1, 2021 | Jul 1, 2021 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Feb 5, 2021 | Feb 8, 2021 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Dec 17, 2020 | Dec 21, 2020 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 44,000 | — | — | 44,000 | Nov 25, 2020 | Apr 29, 2021 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jun 19, 2020 | Jun 23, 2020 ↗ | View → |